Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma

od Spiegl-Kreinecker, S, Pirker, C, Marosi, C, Buchroithner, J, Pichler, J, Silye, R, Fischer, J, Micksche, M, Berger, W
Izdano 2007

Routine psychosocial distress screening in radiotherapy: implementation and evaluation of a computerised procedure

od Dinkel, A, Berg, P, Pirker, C, Geinitz, H, Sehlen, S, Emrich, M, Marten-Mittag, B, Henrich, G, Book, K, Herschbach, P
Izdano 2010

P02.10 Aggressiveness of meningiomas is predicted by cell immortalization in vitro and dependent on TERT promoter mutations

od Spiegl-Kreinecker, S, Lötsch, D, Neumayer, K, Kastler, L, Gojo, J, Pirker, C, Pichler, J, Weis, S, Kumar, R, Webersinke, G, Gruber, A, Berger, W
Izdano u Neuro Oncol (2018)

Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)

od Heffeter, P., Jakupec, M.A., Körner, W., Chiba, P., Pirker, C., Dornetshuber, R., Elbling, L., Sutterlüty, H., Micksche, M., Keppler, B.K., Berger, W.
Izdano 2007

Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance

od Englinger, B, Mair, M, Miklos, W, Pirker, C, Mohr, T, van Schoonhoven, S, Lötsch, D, Körner, W, Ferk, F, Knasmüller, S, Heffeter, P, Keppler, B K, Grusch, M, Berger, W
Izdano u Br J Cancer (2017)

New cellular tools reveal complex epithelial–mesenchymal interactions in hepatocarcinogenesis

od Sagmeister, S, Eisenbauer, M, Pirker, C, Mohr, T, Holzmann, K, Zwickl, H, Bichler, C, Kandioler, D, Wrba, F, Mikulits, W, Gerner, C, Shehata, M, Majdic, O, Streubel, B, Berger, W, Micksche, M, Zatloukal, K, Schulte-Hermann, R, Grasl-Kraupp, B
Izdano 2008